Question 1

Berapa harga saham Johnson & Johnson hari ini?

Accepted Answer

Harga saat ini dari Johnson & Johnson adalah 237.22 USD — harga tersebut telah menurun sebesar -1.20% dalam 24 jam terakhir. Pantau kinerja harga saham Johnson & Johnson lebih dekat di grafik lanjutan.

Question 2

Apa simbol saham Johnson & Johnson?

Accepted Answer

Tergantung pada bursa, simbol saham bisa berbeda. Misalnya, di bursa NYSE, saham Johnson & Johnson diperdagangkan dengan simbol JNJ.

Question 3

Apakah harga saham JNJ naik?

Accepted Answer

Saham JNJ telah menurun sebesar -0.97% dalam seminggu terakhir, telah menurun sebesar -1.80% dalam sebulan terakhir, dan telah meningkat sebesar 53.68% dalam setahun terakhir. Lihat lebih banyak data di grafik JNJ.

Question 4

Apa rekomendasi analis untuk JNJ?

Accepted Answer

Hingga 15 apr 2026, dari 9 rekomendasi analis, mayoritas memberikan rating JNJ sebagai buy.

Question 5

Apa kapitalisasi pasar JNJ?

Accepted Answer

Hingga hari ini, JNJ memiliki kapitalisasi pasar sebesar 573.46B USD. Jelajahi daftar saham kami yang diperingkat berdasarkan kapitalisasi pasar untuk membandingkan JNJ dengan saham lainnya.

Question 6

Apakah JNJ merilis laporan keuangan?

Accepted Answer

Ya, Anda dapat melacak keuangan JNJ dalam laporan tahunan dan kuartalan di Profit.com.

Question 7

Kapan tanggal laporan pendapatan JNJ berikutnya?

Accepted Answer

JNJ akan merilis laporan pendapatan berikutnya pada -. Pantau acara yang akan datang dengan Kalender Pendapatan kami.

Question 8

Berapa pendapatan JNJ untuk kuartal terakhir?

Accepted Answer

JNJ melaporkan pendapatan sebesar $2.46 per saham untuk kuartal terakhir, lebih rendah dibandingkan dengan estimasi $2.46 per saham, yang menghasilkan kejutan -. Estimasi pendapatan untuk kuartal berikutnya adalah $2.68 per saham. Lihat lebih banyak rincian tentang pendapatan JNJ di Profit.com.

Question 9

Berapa pendapatan JNJ untuk kuartal terakhir?

Accepted Answer

Pendapatan JNJ untuk kuartal terakhir adalah 24.56B USD, lebih rendah dibandingkan dengan estimasi 25.33B USD. Estimasi pendapatan untuk kuartal berikutnya adalah 25.15B USD. Lihat lebih banyak statistik di laporan keuangan JNJ di Profit.com.

Question 10

Berapa Laba Bersih JNJ untuk kuartal terakhir?

Accepted Answer

Pendapatan bersih JNJ untuk kuartal terakhir adalah 5.12B USD, sementara kuartal sebelumnya menunjukkan 5.15B USD laba bersih yang mencatatkan perubahan -0.70%. Lihat lebih banyak statistik di laporan keuangan JNJ di Profit.com.

Question 11

¿JNJ paga dividendos?

Accepted Answer

No, JNJ no paga dividendos a sus accionistas. Pero puedes explorar una lista de acciones de alto dividendo en Profit.com.

Question 12

¿Cuántos empleados tiene JNJ?

Accepted Answer

A partir de 15 apr 2026, JNJ emplea aproximadamente a 138200 empleados. Consulta si JNJ está en nuestra lista de empleadores más grandes.

Question 13

¿Qué es el EBITDA de JNJ?

Accepted Answer

El EBITDA, que mide el rendimiento operativo de una empresa, refleja sus mejoras en eficiencia. El EBITDA de JNJ es 33.84B USD, con un margen EBITDA actual de 28.46%. Consulta más estadísticas en los rapporti finanziari de JNJ en Profit.com.

Question 14

¿Cómo comprar acciones de JNJ?

Accepted Answer

Al igual que otras acciones, las acciones de JNJ se cotizan en bolsas de valores como NYSE. La forma más fácil de comprarlas es a través de un bróker de bolsa en línea. Simplemente abre una cuenta, sigue los procedimientos del bróker y comienza a operar. Alternativamente, puedes practicar comerciando acciones de Tesla en Profit.com en torneos Playtrade o elegir un bróker recomendado para operar directamente.

Question 15

¿Debería invertir en las acciones de JNJ?

Accepted Answer

Invertir en acciones requiere una investigación exhaustiva, que incluye analizar las finanzas de la empresa, las noticias relacionadas y el análisis técnico. Actualmente, las recomendaciones de los analistas técnicos de Tesla muestran una calificación de buy.

Antes de invertir en JNJ, considera suscribirte a Profit PRO, donde puedes practicar el comercio en torneos Playtrade, acceder a informes diarios de mercado impulsados por IA, copiar listas de seguimiento cuidadosamente seleccionadas y seguir los portafolios de los multimillonarios.

Johnson & Johnson

⚠️BREAKING: *JOHNSON &amp; JOHNSON 1Q EPS $2.70; EST. $2.68 *JNJ 1Q REVENUE $24.1B; EST. $23.6B $JNJ https://t.co/p83xzBGvxN

Johnson & Johnson considering sale of orthopedics business - report

Johnson & Johnson strikes deal with U.S. government to lower drug prices - CNBC

Johnson & Johnson halts mid-stage trial of experimental eczema drug - CNBC

Johnson & Johnson to buy Halda Therapeutics for $3.05B

⚠️BREAKING: *JOHNSON &amp; JOHNSON 2Q EPS $2.77; EST. $2.68 *JNJ 2Q REVENUE $23.73B; EST. $22.86B $JNJ https://t.co/o73iKfdkiJ

Ethereum Market Cap Surges to $375.5 Billion, Surpassing Johnson & Johnson and Ranking 30th Globally

Johnson & Johnson raises sales outlook, even with tariff costs accounted for

Jim Cramer's week ahead: Earnings from Goldman Sachs, Johnson & Johnson and Netflix

Johnson & Johnson made approach to Intra-Cellular 6 weeks to 2 months ago - report

M&A Snapshot: Johnson & Johnson to acquire Intra-Cellular Therapies in $14.6B CNS-focused deal

Johnson & Johnson makes $15 billion bet on mental-health drugs

Johnson & Johnson exploring takeover of Intra-Cellular - Bloomberg

⚠️BREAKING: *JOHNSON &amp; JOHNSON 3Q EPS $2.42, EST. $2.19 *JNJ 3Q REVENUE $22.50B, EST. $22.17B $JNJ https://t.co/vHWup1EcBA

Johnson & Johnson stock seesaws lower after profit beat, but outlook was lowered

Johnson & Johnson closes acquisition of biotechnology company Proteologix

Johnson & Johnson to buy dermatology-focused biotech Proteologix

Johnson & Johnson tops quarterly profit estimates as medical device sales jump

Johnson & Johnson to acquire Shockwave Medical for $13.1B in cash

Shockwave Medical surges as Johnson & Johnson in talks to acquire - report

Johnson & Johnson to settle talc baby powder investigation, will reportedly pay $700 million - CNBC

⚠️BREAKING: *JOHNSON &amp; JOHNSON 4Q EARNINGS PER SHARE $2.29, EST. $2.28 *JNJ 4Q REV. $21.4B, EST. $21.0B https://t.co/AFYNc3kGXQ 👈 $JNJ https://t.co/MlRGdm66vW

Johnson & Johnson earnings beat estimates with boost from medtech sales

Major Earnings Releases For Tuesday 23rd Of January: $GE $JNJ $MMM $DHI $HAL $PG $RTX $VZ $LMT $NFLX https://t.co/uBEPebRUJu

Johnson & Johnson to acquire ADC developer Ambrx Biopharma for $2B

$JNJ $TEVA | Supreme Court Decision Looms Over Purdue Pharma's $6B Opioid Settlement And Sackler Family Immunity https://t.co/VVRJKLX2Vh

Johnson & Johnson beats on earnings and hikes outlook as medtech, pharmaceutical sales surge

Earnings Watch: Johnson & Johnson earnings: What to expect

Cramer sours on Johnson & Johnson as lawsuits pile up

Johnson & Johnson effort to resolve talc cancer lawsuits in bankruptcy fails a second time

Johnson & Johnson to reduce its Kenvue stake by at least 80% through exchange offer

Johnson & Johnson launches Kenvue exchange offer (NYSE:JNJ) - Seeking Alpha

Stocks making the biggest moves midday: Netflix, American Airlines, Johnson & Johnson and more

*U.S. FDA REVOKES EMERGENCY USE AUTHORIZATION FOR J&J'S COVID VACCINE https://t.co/CFKEtW5IjL $JNJ https://t.co/6tcyE2yjgJ

Johnson & Johnson's consumer health unit Kenvue started trading. What it means for J&J shareholders like us - CNBC

Johnson & Johnson to price shares of consumer spinoff Kenvue at $20 to $23 in IPO - CNBC

Johnson & Johnson consumer health unit valued at $40 billion ahead of IPO, report says

4 Stock Market Morning Movers: $NVDA $BLU $GS $JNJ Check out the Details 👇 https://t.co/zxQGPEOfWa

The markets are open!🔔 Here are some things in focus today.👇 ✧ Building permits (Mar) ✦ Housing starts (Mar) ✧ Fed Bowman speech ✦ $NFLX, $GS, $BAC, $JNJ, $LMT, $ISRG, $UAL, and more earnings! https://t.co/XyPV5QWJw8

Johnson & Johnson swings to loss as it books multibillion-dollar charge to settle talc claims

Stocks making the biggest moves premarket: Johnson & Johnson, Goldman Sachs, Sunrun and more - CNBC

⚠️BREAKING: *JOHNSON & JOHNSON 1Q EARNINGS PER SHARE $2.68, EST. $2.50 *JOHNSON & JOHNSON 1Q REV. $24.7B, EST. $23.6B https://t.co/upc7H4lBiI $JNJ https://t.co/0tdJfX6bwq

Major #Earnings Releases Tuesday 18th April $JNJ $BAC $NFLX $LMT $GS $UAL https://t.co/IJD8JKvzpK

first full week of #earnings season https://t.co/lObOE0dgsr $TSLA $SCHW $BAC $NFLX $JNJ $GS $MTB $STT $TSM $ASML $LMT $MS $UAL $AXP $RAD $T $BK $PLD $GNTY $IBM $USB $NOK $PG $ERIC $ISRG $NDAQ $BKR $ABT $ALK $SLB $ALLY $MBWM $WAL $FCX $BX $JBHT $UNP $CBSH $DHI $PM $ELV $AA… https://t.co/CDZXPSGHTx

JNJ, AbbVie plan to pull US accelerated approvals for some blood cancer treatments https://t.co/6k1Mj4IbBf https://t.co/zjQf97LRpd

FAQ

⚠️BREAKING: JOHNSON & JOHNSON 1Q EPS $2.70; EST. $2.68 JNJ 1Q REVENUE $24.1B; EST. $23.6B $JNJ https://t.co/p83xzBGvxN

⚠️BREAKING: JOHNSON & JOHNSON 2Q EPS $2.77; EST. $2.68 JNJ 2Q REVENUE $23.73B; EST. $22.86B $JNJ https://t.co/o73iKfdkiJ

⚠️BREAKING: JOHNSON & JOHNSON 3Q EPS $2.42, EST. $2.19 JNJ 3Q REVENUE $22.50B, EST. $22.17B $JNJ https://t.co/vHWup1EcBA

⚠️BREAKING: JOHNSON & JOHNSON 4Q EARNINGS PER SHARE $2.29, EST. $2.28 JNJ 4Q REV. $21.4B, EST. $21.0B https://t.co/AFYNc3kGXQ 👈 $JNJ https://t.co/MlRGdm66vW

⚠️BREAKING: JOHNSON & JOHNSON 1Q EARNINGS PER SHARE $2.68, EST. $2.50 JOHNSON & JOHNSON 1Q REV. $24.7B, EST. $23.6B https://t.co/upc7H4lBiI $JNJ https://t.co/0tdJfX6bwq